UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Tandem Capital Management Corp ADV

Tandem Capital Management Corp ADV trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,604 shares of the healthcare conglomerate’s stock after selling 91 shares during the quarter. Tandem Capital Management Corp ADV’s holdings in UnitedHealth Group were worth $1,371,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Robbins Farley purchased a new position in UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the fourth quarter valued at $26,000. CGC Financial Services LLC increased its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA grew its position in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.4 %

Shares of NYSE UNH traded up $6.58 on Thursday, hitting $493.88. The company had a trading volume of 4,329,383 shares, compared to its average volume of 4,530,458. The business has a 50 day moving average of $486.36 and a two-hundred day moving average of $514.42. The firm has a market capitalization of $454.41 billion, a P/E ratio of 30.19, a PEG ratio of 1.41 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.26 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on UNH shares. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.